28081741|t|Depletion of NFBD1 / MDC1 Induces Apoptosis in Nasopharyngeal Carcinoma Cells Through the p53 - ROS - Mitochondrial Pathway
28081741|a|NFBD1, a signal amplifier of the p53 pathway, is vital for protecting cells from p53 -mediated apoptosis and the early phase of DNA damage response under normal culture conditions. Here we investigated its expression in patients with nasopharyngeal carcinoma (NPC), and we describe the biological functions of the NFBD1 gene. We found that NFBD1 mRNA and protein were more highly expressed in NPC tissues than in nontumorous tissues. To investigate the function of NFBD1, we created NFBD1 - depleted NPC cell lines that exhibited decreased cellular proliferation and colony formation, an increase in their rate of apoptosis, and an enhanced sensitivity to chemotherapeutic agents compared with in vitro controls. However, N-acetyl cysteine (NAC) and downregulation of p53 expression could partially reverse the apoptosis caused by the loss of NFBD1. Further analysis showed that loss of NFBD1 resulted in increased production of intracellular reactive oxygen species (ROS) depending on p53, which subsequently triggered the mitochondrial apoptotic pathwa y. Using a xenograft model in nude mice, we showed that silencing NFBD1 also significantly inhibited tumor growth and led to apoptosis. Taken together, our data suggest that inhibition of NFBD1 in NPC could be therapeutically useful.
28081741	0	9	Depletion	T169	C0333668
28081741	13	18	NFBD1	T028	C1427378
28081741	21	25	MDC1	T028	C1427378
28081741	26	33	Induces	T169	C0205263
28081741	34	43	Apoptosis	T043	C0162638
28081741	47	71	Nasopharyngeal Carcinoma	T191	C2931822
28081741	72	77	Cells	T025	C0007634
28081741	78	85	Through	T169	C0332273
28081741	90	93	p53	T116,T123	C0080055
28081741	96	99	ROS	T123,T196	C0162772
28081741	102	123	Mitochondrial Pathway	T044	C3270989
28081741	124	129	NFBD1	T028	C1427378
28081741	157	168	p53 pathway	T044	C2756034
28081741	183	199	protecting cells	T039	C0524828
28081741	205	208	p53	T116,T123	C0080055
28081741	219	228	apoptosis	T043	C0162638
28081741	252	271	DNA damage response	T043	C1155291
28081741	278	303	normal culture conditions	T059	C0007585
28081741	330	340	expression	T045	C1171362
28081741	344	352	patients	T101	C0030705
28081741	358	382	nasopharyngeal carcinoma	T191	C2931822
28081741	384	387	NPC	T191	C2931822
28081741	410	430	biological functions	T038	C3714634
28081741	438	448	NFBD1 gene	T028	C1427378
28081741	464	469	NFBD1	T028	C1427378
28081741	470	474	mRNA	T114,T123	C0035696
28081741	479	486	protein	T116,T123	C0033684
28081741	497	503	highly	T080	C0205250
28081741	504	513	expressed	T045	C0017262
28081741	517	520	NPC	T191	C2931822
28081741	521	528	tissues	T024	C1292533
28081741	537	548	nontumorous	T033	C0243095
28081741	549	556	tissues	T024	C1292533
28081741	577	585	function	T044	C1527118
28081741	589	594	NFBD1	T028	C1427378
28081741	607	612	NFBD1	T028	C1427378
28081741	615	623	depleted	T169	C0333668
28081741	624	627	NPC	T191	C2931822
28081741	628	638	cell lines	T025	C0007600
28081741	664	686	cellular proliferation	T043	C0596290
28081741	691	697	colony	T025	C1947989
28081741	698	707	formation	T169	C1522492
28081741	712	720	increase	T169	C0442805
28081741	730	734	rate	T081	C1521828
28081741	738	747	apoptosis	T043	C0162638
28081741	756	764	enhanced	T052	C2349975
28081741	765	776	sensitivity	T080	C1522640
28081741	780	803	chemotherapeutic agents	T121	C0729502
28081741	818	826	in vitro	T080	C1533691
28081741	846	863	N-acetyl cysteine	T116,T121	C0001047
28081741	865	868	NAC	T116,T121	C0001047
28081741	874	888	downregulation	T044	C0013081
28081741	892	906	p53 expression	T045	C1171362
28081741	913	922	partially	T081	C0728938
28081741	923	930	reverse	T169	C1555029
28081741	935	944	apoptosis	T043	C0162638
28081741	959	963	loss	T081	C1517945
28081741	967	972	NFBD1	T028	C1427378
28081741	1003	1007	loss	T081	C1517945
28081741	1011	1016	NFBD1	T028	C1427378
28081741	1029	1038	increased	T081	C0205217
28081741	1053	1066	intracellular	T082	C0178719
28081741	1067	1090	reactive oxygen species	T123,T196	C0162772
28081741	1092	1095	ROS	T123,T196	C0162772
28081741	1110	1113	p53	T116,T123	C0080055
28081741	1121	1133	subsequently	T079	C0332282
28081741	1134	1143	triggered	T080	C1444748
28081741	1148	1178	mitochondrial apoptotic pathwa	T044	C3269143
28081741	1190	1205	xenograft model	T050	C1520166
28081741	1209	1218	nude mice	T015	C0025932
28081741	1235	1244	silencing	T045	C0598496
28081741	1245	1250	NFBD1	T028	C1427378
28081741	1270	1279	inhibited	T052	C3463820
28081741	1280	1292	tumor growth	T191	C0598934
28081741	1304	1313	apoptosis	T043	C0162638
28081741	1353	1363	inhibition	T052	C3463820
28081741	1367	1372	NFBD1	T028	C1427378
28081741	1376	1379	NPC	T191	C2931822
28081741	1389	1404	therapeutically	T061	C0087111
28081741	1405	1411	useful	T080	C3827682